(Q40338899)

English

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study

scientific article published on October 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Kim-Anh Lê Cao

4

object named as

Kim-Anh Lê Cao

0 references

object named as

Clare Gould

11

0 references

object named as

Colm Keane

1

0 references

Rodney J. Hicks

object named as

Rodney J Hicks

8

0 references

Dipti Talaulikar

14

object named as

Dipti Talaulikar

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Frank Vari

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mark Hertzberg

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kim-Anh Lê Cao

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Michael R Green

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Erica Han

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

John F Seymour

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Devinder Gill

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pauline Crooks

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kimberley Jones

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lyn R Griffiths

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sanjiv Jain

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Josh Tobin

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Maher K Gandhi

17

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The Lancet. Haematology.

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

e445-55

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

State-of-the-art therapeutics: diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunodeficiency-associated lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stromal gene signatures in large-B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating giant macrophages as a potential biomarker of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Appraisal of immune response in lymphoproliferative syndromes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct multiplexed measurement of gene expression with color-coded probe pairs

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New biologic agents and immunologic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 blockade induces responses by inhibiting adaptive immune resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900150-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2352-3026(15)00150-7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40338899&oldid=2133278308"